The Cardiology Unit continues to develop its research program in association with key areas of clinical service.
In addition to the link with the University of Melbourne Department of Medicine – Western Precinct, collaborative ties with Victoria University, Monash University and the Baker Institute were strengthened. The unit looks forward to ongoing increased growth and research output in the year to come.
Current active commercially sponsored clinical trials:
PREVAIL: Obicetrapib and Cardiovascular Outcomes: A Placebo-Controlled, Double-Blind, Randomized Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With Atherosclerotic Cardiovascular Disease (ASCVD) Who are Not Adequately Controlled Despite Maximally Tolerated Lipid-Modifying Therapies. Sponsor: NewAmsterdam Pharma BV, The Netherlands Principal Investigator: Dr Ben Costello
Page last updated November 2022
